Epigenome-targeted therapy for cholangiocarcinoma.

Project Information

EpiTarget

Grant agreement ID: 709161

DOI 10.3030/709161

Project closed

EC signature date 18 March 2016

Start date 1 February 2017

End date 31 January 2019

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 200 194,80

EU contribution € 200 194,80

Coordinated by

KOBENHAVNS UNIVERSITET
Denmark

Publications

Peer reviewed articles (2)

Epigenome dysregulation in cholangiocarcinoma

Author(s): Colm J.O'Rourke, Patricia Munoz-Garrido, Esmeralda L.Aguayo, Jesper B.Andersen
Published in: Biochimica et biophysica acta - Molecular basis of disease, Issue Volume 1864, Issue 4, Part B, 2018, Page(s) 1423-1434, ISSN 0925-4439
Publisher: Elsevier BV

Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma

Author(s): Chirag Nepal Colm J. O'Rourke Douglas V.N.P. Oliveira Andrzej Taranta Steven Shema Prson Gautam Julien Calderaro Andrew Barbour Chiara Raggi Krister Wennerberg Xin W. Wang Anja Lautem Lewis R. Roberts Jesper B. Andersen
Published in: Hepatology, Issue 68(3), 2018, Page(s) 949-963, ISSN 1527-3350
Publisher: Wiley Online Library - AASLD Journals